UNSPSC 51422333: Dexamethasone acetate

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E2287TKU04. European Medicines Agency schedules Dexamethasone acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01608MIG. Dexamethasone acetate generally arises in the molecular formula C24H31FO6. The term 'dexamethasone acetate' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule dexamethasone acetate under HS 29372200 and SITC 54153.

Dexamethasone acetate bears US NLM identifiers UMLS ID C0057598 and NCI Concept Code C1067. SMILES: As of Q4 2014, DEXAMETHASONE ACETATE remains US FDA's Preferred Term for this commodity.

UNSPSC 51422333 Dexamethasone acetate is a Commodity code that represents a single pharmaceutical product line. However, the recent state and local opportunities tagged under this code show a significant mismatch: neither the Seminole County naloxone and drug deactivation systems procurement nor the Texas Health and Human Services Commission's Therapeutic Pharmacy Initiative RFI involve dexamethasone acetate procurement. State and local governments soliciting under this code in the recent period are actually buying pharmaceutical products and pharmacy benefit management services, but the specific recent postings do not reflect dexamethasone acetate as the focus of active buying activity. The issuing bodies include county health departments and state health agencies pursuing broader pharmacy and pharmaceutical distribution arrangements.

Activity under this code is geographically limited to recent visibility in Florida and Texas, with the Seminole County Community Health Building sourcing naloxone and drug deactivation systems on an IFB basis with a response date of July 26, 2023, and the Texas HHS Commission gathering market intelligence through an RFI posted April 3, 2026 regarding direct-to-manufacturer prescription fulfillment. The code shows little focused procurement activity on dexamethasone acetate itself in the recent-opportunities window, suggesting either limited state and local demand for this specific product or systematic mis-coding at the point of solicitation. Vendors should verify current and upcoming opportunities directly with county health departments and state pharmacy agencies rather than relying on this code's historical tagging.